Calliditas Therapeutics
confirmatory proof of concept observed in phase trial | Calliditas Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
12 of 38
Related slides by other companies
argenx SE
Investor Day
July 2021
phase safety results support proof of concept studies in patients | argenx SE
ATAI
Investor Presentation
November 2022
milestone highlights in anticipated catalysts across we will build on recent success by delivering several meaningful our key programs | ATAI
MindMed
Investor Presentation
November 2024
phase trial schematic schematic | MindMed
AstraZeneca
Results
February 2021
building new standard of care | AstraZeneca
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights